Sema4|GeneDx to Participate in the 41st Annual J.P. Morgan Healthcare Conference
30 déc. 2022 08h30 HE
|
Sema4
STAMFORD, Conn., Dec. 30, 2022 (GLOBE NEWSWIRE) -- Sema4 (Nasdaq: SMFR), a health insights company, today announced the company will participate in the 41st Annual J.P. Morgan Healthcare Conference...